Stein Stephen W, Myrdal Paul B, Gabrio Brian J, Obereit Derek, Beck Tyler J
3M Drug Delivery Systems Division, Inhalation Drug Delivery Laboratory, Saint Paul, Minnesota 55144, USA.
J Aerosol Med. 2003 Summer;16(2):107-19. doi: 10.1089/089426803321919870.
The ability of the Model 3320 and newer Model 3321 Aerodynamic Particle Sizer Spectrometer (APS) to make accurate mass-weighted size distribution measurements of solution metered dose inhalers (MDIs) was evaluated. Measurements of experimental HFA-134a beclomethasone dipropionate MDIs were made with both the APS 3320 and APS 3321 and compared to the Andersen Cascade Impactor (ACI). The mass-weighted size distribution measurements from the ACI and APS 3321 agreed well but were very different than the APS 3320 measurements. Evaluation of the APS 3320 size distribution measurements indicated that the presence of a few erroneous particle measurements caused a gross overestimation of the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD). When a previously described technique was used to eliminate erroneous particle size measurements from the size distribution calculation, the MMAD and GSD from the APS 3320 agreed well with those from the ACI and APS 3321. The GSD from the APS 3321 and the APS 3320 after a mask was applied were slightly larger than from the ACI. It is believed that both APS instruments slightly underestimate the GSD while the ACI slightly overestimates the GSD. Further experiments were conducted using the APS 3321 to examine the influence of drug concentration and cosolvent level on the size distribution of solution formulation MDIs. The MMAD was shown experimentally and theoretically to be proportional to drug concentration to the one-third power. Cosolvent concentration had minimal influence on MMAD over the range examined. The measurements reported in this paper demonstrate that it is possible to obtain accurate mass-weighted size distribution measurements with the APS 3320 and APS 3321. These instruments allow for accurate size distribution measurements to be made in minutes as opposed to the hours required to conduct and analyze size distribution measurements from cascade impactors.
对3320型及更新的3321型空气动力学粒径谱仪(APS)进行溶液定量吸入器(MDI)准确的质量加权粒径分布测量的能力进行了评估。使用APS 3320和APS 3321对实验性氢氟烷烃-134a倍氯米松二丙酸酯MDI进行测量,并与安德森级联撞击器(ACI)进行比较。ACI和APS 3321的质量加权粒径分布测量结果吻合良好,但与APS 3320的测量结果差异很大。对APS 3320粒径分布测量的评估表明,少数错误的颗粒测量导致质量中值空气动力学直径(MMAD)和几何标准差(GSD)被严重高估。当使用先前描述的技术从粒径分布计算中消除错误的粒径测量时,APS 3320的MMAD和GSD与ACI和APS 3321的结果吻合良好。应用遮罩后,APS 3321和APS 3320的GSD略大于ACI的。据信,两种APS仪器都略微低估了GSD,而ACI则略微高估了GSD。使用APS 3321进行了进一步实验,以研究药物浓度和助溶剂水平对溶液制剂MDI粒径分布的影响。实验和理论均表明,MMAD与药物浓度的三分之一次方成正比。在所研究的范围内,助溶剂浓度对MMAD的影响最小。本文报道的测量结果表明,使用APS 3320和APS 3321可以获得准确的质量加权粒径分布测量结果。与级联撞击器进行粒径分布测量并分析所需的数小时相比,这些仪器能够在几分钟内进行准确的粒径分布测量。